|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | ||
| Impairment of capitalized software development costs | ||
| Stock-based compensation expense | ||
| Common stock warrant expense | ||
| Credit loss expense | ||
| Impairment of equity investment | ||
| Amortization of debt discount and issuance costs | ||
| Change in fair value of convertible notes derivative liability | ||
| Deferred income taxes | ||
| Other | ||
| Changes in assets and liabilities: | ||
| Accounts receivable | ||
| Other current and long-term assets | ||
| Accounts payable | ||
| Due to third-party publishers | ||
| Accrued expenses | ||
| Deferred revenue | ||
| User redemption liability | ||
| Other current and long-term liabilities | ||
| Net cash provided by operating activities | ||
| Investing activities | ||
| Additions to property and equipment | ||
| Additions to capitalized software development costs | ||
| Acquisition of technology | ||
| Purchases of short-term investments | ||
| Proceeds from Sale of Short-Term Investments | ||
| Maturities of short-term investments | ||
| Net cash (used in) provided by investing activities | ||
| Financing activities | ||
| Proceeds from exercise of stock options | ||
| Draws on revolving line of credit | ||
| Repayments of revolving line of credit | ||
| Proceeds from convertible notes issuance | ||
| Debt issuance costs | ||
| Proceeds from initial public offering, net | ||
| Purchase of treasury stock | ||
| Taxes paid related to net share settlement of equity awards | ||
| Deferred offering costs | ||
| Proceeds from employee stock purchase plan | ||
| Other financing activities | ||
| Net cash (used in) provided by financing activities | ||
| Net change in cash, cash equivalents, and restricted cash | ||
| Cash, cash equivalents, and restricted cash, beginning of period | ||
| Cash, cash equivalents, and restricted cash, end of period | ||
| Supplemental disclosures of cash flow information | ||
| Interest paid | ||
| Income taxes paid | ||
| Supplemental disclosures of non-cash investing and financing activities | ||
| Share repurchases in accounts payable and accrued expenses | ||
| Stock-based compensation included in capitalized software development costs | ||
| Conversion of convertible debt into Class A common stock | ||
| Property and equipment in accounts payable and accrued expenses |
Loading...
